|
SANA Sana Biotechnology Inc 1770121 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-47,210,000.00 |
| Balance Sheet |
|
Current Assets
|
$111,690,000.00 |
|
Assets
|
$373,593,000.00 |
|
Current Liabilities
|
$86,265,000.00 |
|
Liabilities
|
$254,353,000.00 |
|
Equity
|
$119,240,000.00 |
|
Shares Out
|
269817000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-37,379,000.00 |
|
Investing Cash Flow
|
$49,437,000.00 |
| Market Analysis |
Market Cap
|
$876,905,250.00 |
|
Price
|
$3.09 |
|
BVPS
|
0.44 |
|
PB
|
7.39 |
|
EPS
|
-0.17 |
|
FCF
|
$-37,667,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-0.16 |
|
|
2026-05-11 |
-0.14 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.16 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.16 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SANA documents filed with the SEC.
SANA Filings
Clear
